Panakeia Technologies Limited

Startup

Panakeia is changing the way biomarker testing is done using AI and is improving real-world treatment for patients. Our AI software platform enables multi-omic biomarker testing, from routinely used tissue images. We offer biomarker results in minutes instead of days or weeks. Panakeia's technology has the potential to enable patients getting treatment in <1 week instead of 30 days and help select the most appropriate patients for cancer drug trials, significantly improving success rates.